|本期目录/Table of Contents|

[1]董国璋,许林.挥发性有机化合物在肿瘤早期筛查中的研究进展[J].医学研究与战创伤救治(原医学研究生学报),2021,23(03):302-306.[doi:10.3969/j.issn.1672-271X.2021.03.017]
　DONG Guo-zhang,XU Lin.Research progress of volatile organic compounds in early tumor screening[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2021,23(03):302-306.[doi:10.3969/j.issn.1672-271X.2021.03.017]
点击复制

挥发性有机化合物在肿瘤早期筛查中的研究进展()
分享到62.8K

《医学研究与战创伤救治》（原医学研究生学报）[ISSN:1672-271X/CN:32-1713/R]

卷:
第23卷
期数:
2021年03期
页码:
302-306
栏目:
综述
出版日期:
2021-06-20

文章信息/Info

Title:
Research progress of volatile organic compounds in early tumor screening
作者:
董国璋; 许林
作者单位：210009南京，南京医科大学附属肿瘤医院 江苏省肿瘤防治研究所 江苏省肿瘤医院胸外科(董国璋、许林)
Author(s):
DONG Guo-zhang ;  XU Lin
(Department of Thoracic Surgery,the Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Institute of Cancer Research, Jiangsu Cancer Hospital, Nanjing 210009, Jiangsu, China)
关键词:
挥发性有机化合物; 癌症; 代谢组学
Keywords:
volatile organic compounds;  cancer;  metabolomics
分类号:
R73
DOI:
10.3969/j.issn.1672-271X.2021.03.017
文献标志码:
A
摘要:
肿瘤是危害人类健康的重要疾病，具有高发病率和高病死率的特点。早期肿瘤的准确筛查显得尤为重要。对于人体代谢产物中的挥发性部分（VOCs）的分析是目前癌症早期筛查的一个新兴研究领域。VOCs的变化像是“气体印记”一样，可在多种疾病中有所体现，间接反映身体健康状况。作为一种无创、便捷的肿瘤早期筛查方式，VOCs的分析已经成功的应用于多种肿瘤的早期诊断，并取得一定的成功。但是目前技术上的困难仍然限制了VOC分析在临床上的广泛应用。文章主要就当前挥发性有机物分析的研究现状及其优势以及当前面临的问题进行综述。
Abstract:
Tumor is an important disease endangering human health, and it has the characteristics of high morbidity and high mortality. The accurate screening of early tumors is particularly important. The analysis of volatile organic compounds (VOCs) in human metabolites is currently an emerging research field in early cancer screening. The change of VOCs is like a "gas mark", which can be reflected in a variety of diseases and indirectly reflect the health of the body. As a non-invasive and convenient way of early tumor screening, the analysis of VOCs has been successfully applied to the early diagnosis of a variety of tumors with certain success. However, the current technical difficulties still limit the wide application of VOC analysis in clinical practice. This review mainly describes the current research status of volatile organic compounds analysis, its advantages and current problems.

参考文献/References:

[1]Schmidt K, Podmore I. Current Challenges in Volatile Organic Compounds Analysis as Potential Biomarkers of Cancer[J]. J Biomarkers, 2015, 2015(3): 981458.
[2]Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. Ca Cancer J Clin, 2018, 68(6): 394-424.
[3]Horváth I, Lázár Z, Gyulai N, et al. Exhaled biomarkers in lung cancer[J]. Eur Respir J, 2009, 34(1): 261-275.
[4]Phillips M, Cataneo RN, Greenberg J, et al. Effect of oxygen on breath markers of oxidative stress[J]. Eur Respir J, 2003, 21(1): 48-51.
[5]Peng G, Hakim M, Broza YY, et al. Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors[J]. Brit J Cancer, 2010, 103(4): 542-551.
[6]Pauling L, Robinson AB, Teranishi R, et al. Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography[J]. Pnatl Acad Sci USA, 1971, 68(10): 2374-2376.
[7]Gordon SM, Szidon JP, Krotoszynski BK, et al. Volatile organic compounds in exhaled air from patients with lung cancer[J]. Clin Chem, 1985, 31(8): 1278-1282.
[8]Spanel P, Smith D, Holland TA, et al. Analysis of formaldehyde in the headspace of urine from bladder and prostate cancer patients using selected ion flow tube mass spectrometry[J]. Rapid Commun Mass, 1999, 13(14): 1354-1359.
[9]Huang J, Kumar S, Abbassi-Ghadi N, et al. Selected ion flow tube mass spectrometry analysis of volatile metabolites in urine headspace for the profiling of gastro-esophageal cancer[J]. Anal Chem, 2013, 85(6): 3409-3416.
[10]Batty CA, Cauchi M, Loureno C, et al. Use of the Analysis of the Volatile Faecal Metabolome in Screening for Colorectal Cancer[J]. PLoS One, 2015, 10(6): e0130301.
[11]Smith D, Wang T, Sulé-Suso J, et al. Quantification of acetaldehyde released by lung cancer cells in vitro using selected ion flow tube mass spectrometry[J]. Rapid Commun Mass, 2003, 17(8): 845-850.
[12]Van De Goor R, Van Hooren M, Dingemans AM, et al. Training and Validating a Portable Electronic Nose for Lung Cancer Screening[J]. J Thorac Oncol, 2018, 13(5): 676-681.
[13]Feinberg T, Alkoby-Meshulam L, Herbig J, et al. Cancerous glucose metabolism in lung cancer-evidence from exhaled breath analysis[J]. J Breathres, 2016, 10(2): 026012.
[14]Handa H, Usuba A, Maddula S, et al. Exhaled breath analysis for lung cancer detection using ion mobility spectrometry[J]. PLoS One, 2014, 9(12): e114555.
[15]O’neill HJ, Gordon SM, O’neill MH, et al. A computerized classification technique for screening for the presence of breath biomarkers in lung cancer[J]. Clin Chem, 1988, 34(8): 1613-1618.
[16]Preti G, Labows JN, Kostelc JG, et al. Analysis of lung air from patients with bronchogenic carcinoma and controls using gas chromatography-mass spectrometry[J]. J Chromatogr, 1988, 432:1-11.
[17]Khyshiktyev BS, Khyshiktueva NA, Ivanov VN, et al. Diagnostic value of investigating exhaled air condensate in lung cancer[J]. Vop Onk, 1994, 40(4-6): 161-164.
[18]Phillips M, Gleeson K, Hughes JM, et al. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study[J]. Lancet, 1999, 353(9168): 1930-1933.
[19]Phillips M, Cataneo RN, Cummin AR, et al. Detection of lung cancer with volatile markers in the breath[J]. Chest, 2003, 123(6): 2115-2123.
[20]Phillips M, Bauer TL, Pass HI. A volatile biomarker in breath predicts lung cancer and pulmonary nodules[J]. J Breath Res, 2019, 13(3): 036013.
[21]Fuchs P, Loeseken C, Schubert JK, et al. Breath gas aldehydes as biomarkers of lung cancer[J]. Int J Cancer, 2010, 126(11): 2663-2670.
[22]Wang C, Dong R, Wang X, et al. Exhaled volatile organic compounds as lung cancer biomarkers during one-lung ventilation[J]. Sci Rep, 2014, 2014(4):7312.
[23]Peralbo-Molina A, Calderón-Santiago M, Priego-Capote F, et al. Identification of metabolomics panels for potential lung cancer screening by analysis of exhaled breath condensate[J]. J Breath Res, 2016, 10(2): 026002.
[24]Hakim M, Broza YY, Barash O, et al. Volatile organic compounds of lung cancer and possible biochemical pathways[J]. Chem Rev, 2012, 112(11): 5949-5966.
[25]Altomare DF, Di Lena M, Porcelli F, et al. Exhaled volatile organic compounds identify patients with colorectal cancer[J]. Brit J Surg, 2013, 100(1): 144-150.
[26]Altomare DF, Di Lena M, Porcelli F, et al. Effects of Curative Colorectal Cancer Surgery on Exhaled Volatile Organic Compounds and Potential Implications in Clinical Follow-up[J]. Ann Surg, 2015, 262(5): 862-866.
[27]Kumar S, Huang J, Abbassi-Ghadi N, et al. Mass Spectrometric Analysis of Exhaled Breath for the Identification of Volatile Organic Compound Biomarkers in Esophageal and Gastric Adenocarcinoma[J]. Ann Surg, 2015, 262(6): 981-990.
[28]Chen Y, Zhang Y, Pan F, et al. Breath Analysis Based on Surface-Enhanced Raman Scattering Sensors Distinguishes Early and Advanced Gastric Cancer Patients from Healthy Persons[J]. Acs Nano, 2016, 10(9): 8169-8179.
[29]Silva CL, Passos M, Cmara JS. Investigation of urinary volatile organic metabolites as potential cancer biomarkers by solid-phase microextraction in combination with gas chromatography-mass spectrometry[J]. Brit J Cancer, 2011, 105(12): 1894-1904.
[30]Arasaradnam RP, Mcfarlane MJ, Ryan-Fisher C, et al. Detection of colorectal cancer (CRC) by urinary volatile organic compound analysis[J]. PLoS One, 2014, 9(9): e108750.
[31]Westenbrink E, Arasaradnam RP, O’connell N, et al. Development and application of a new electronic nose instrument for the detection of colorectal cancer[J]. Biosens Bioelectron, 2015, 2015(67):733-738.
[32]Arasaradnam RP, Wicaksono A, O’brien H, et al. Noninvasive Diagnosis of Pancreatic Cancer Through Detection of Volatile Organic Compounds in Urine[J]. Gastroenterology, 2018, 154(3): 485-487.
[33]Lima AR, Pinto J, Azevedo AI, et al. Identification of a biomarker panel for improvement of prostate cancer diagnosis by volatile metabolic profiling of urine[J]. Brit J Cancer, 2019, 121(10): 857-868.
[34]De Meij TG, Larbi IB, Van Der Schee MP, et al. Electronic nose can discriminate colorectal carcinoma and advanced adenomas by fecal volatile biomarker analysis: proof of principle study[J]. Int J Cancer, 2014, 134(5): 1132-1138.
[35]Navaneethan U, Parsi MA, Gutierrez NG, et al. Volatile organic compounds in bile can diagnose malignant biliary strictures in the setting of pancreatic cancer: a preliminary observation[J]. Gastrointest Endosc, 2014, 80(6): 1038-1045.
[36]Navaneethan U, Parsi MA, Lourdusamy V, et al. Volatile organic compounds in bile for early diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis: a pilot study[J]. Gastrointest Endosc, 2015, 81(4): 943-949.
[37]Navaneethan U, Spencer C, Zhu X, et al. Volatile organic compounds in bile can distinguish pancreatic cancer from chronic pancreatitis: a prospective observational study[J]. Endoscopy, 2020.doi:10.1055/a-1255-9169.

相似文献/References:

备注/Memo

备注/Memo:
-
更新日期/Last Update: 2021-06-17